TargetMol

DOPEXAMINE

Product Code:
 
TAR-T8653
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T8653-1mg1mg£177.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8653-2mg2mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8653-5mg5mg£310.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8653-1mL1 mL * 10 mM (in DMSO)£330.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8653-10mg10mg£434.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8653-25mg25mg£670.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8653-50mg50mg£914.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8653-100mg100mg£1,211.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Dopexamine is a dopaminergic agonist
CAS:
86197-47-9
Formula:
C22H32N2O2
Molecular Weight:
356.51
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.98
SMILES:
Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O
Target:
Dopamine Receptor

References

Napoleone P , Ricci A , Ferrante F , et al. Dopexamine hydrochloride in the human heart: receptor binding and effects on cAMP generation[J]. European Heart Journal, 1993, 13(12):1709-1717. Perrin G , Papazian L , Martin C . [Dopexamine: a new dopaminergic agonist].[J]. Ann Fr Anesth Reanim, 1993, 12(3):308-320. Eley K A , Young J D , Watt-Smith S R . Epinephrine, norepinephrine, dobutamine, and dopexamine effects on free flap skin blood flow.[J]. Plastic & Reconstructive Surgery, 2012, 130(3):564.